ORKA

Oruka Therapeutics, Inc. Common Stock

16 hedge funds and large institutions have $27.9M invested in Oruka Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
3
Increased
4
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NMC
1
NEA Management Company
Maryland
$6.79M 1,460,209
Franklin Resources
2
Franklin Resources
California
$5.66M 1,216,840
VMI
3
VHCP Management II
New York
$5.02M 1,078,932 +1,078,932 New
TCM
4
Tekla Capital Management
Massachusetts
$3.77M 811,227
RCM
5
RA Capital Management
Massachusetts
$3.62M 778,211 -33,016 -4%
VM
6
VHCP Management
New York
$2.15M 462,399 -1,078,932 -70%
Vanguard Group
7
Vanguard Group
Pennsylvania
$553K 119,001 +31,802 +36%
Deutsche Bank
8
Deutsche Bank
Germany
$175K 37,700 +12,600 +50%
Citadel Advisors
9
Citadel Advisors
Florida
$83K 17,811 +17,811 New
VKH
10
Virtu KCG Holdings
New York
$68K 14,517 +4,312 +42%
Bank of America
11
Bank of America
North Carolina
$3K 576 -1,572 -73%
BFA
12
BlackRock Fund Advisors
California
$3K 590 +590 New
TRCT
13
Tower Research Capital (TRC)
New York
$1K 119 -8,329 -99%
Wells Fargo
14
Wells Fargo
California
$1K 142
Citigroup
15
Citigroup
New York
$1K 263 +262 +26,200%
UBS Group
16
UBS Group
Switzerland
$0 27 -948 -97%
Walleye Trading
17
Walleye Trading
New York
-700 Closed